Ovarian hyperstimulation syndrome (OHSS): New strategies of prevention and treatment

被引：15
作者：
Chen, Shee-Uan [1 ]
Chen, Chin-Der [1 ]
Yang, Yu-Shih [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 100, Taiwan
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2008年 / 107卷 / 07期
关键词：
D O I：
10.1016/S0929-6646(08)60162-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：509 / 512
页数：4
相关论文
共 11 条
[1]   Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment:: a pilot study [J].
Alvarez, Claudio ;
Alonso-Muriel, Isabel ;
Garcia, Gabriela ;
Crespo, Juana ;
Bellver, Jose ;
Simon, Carlos ;
Pellicer, Antonio .
HUMAN REPRODUCTION, 2007, 22 (12) :3210-3214
[2]   Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction [J].
Alvarez, Claudio ;
Marti-Bonmati, Luis ;
Novella-Maestre, Edurne ;
Sanz, Roberto ;
Gomez, Raul ;
Fernandez-Sanchez, Manuel ;
Simon, Carlos ;
Pellicer, Antonio .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) :2931-2937
[3]   The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor [J].
Basu, S ;
Nagy, JA ;
Pal, S ;
Vasile, E ;
Eckelhoefer, IA ;
Bliss, VS ;
Manseau, EJ ;
Dasgupta, PS ;
Dvorak, HF ;
Mukhopadhyay, D .
NATURE MEDICINE, 2001, 7 (05) :569-574
[4]   Comoarison of coastina and intravenous albumin in the prevention of ovarian hyperstimulation syndrome [J].
Chen, CD ;
Chao, KH ;
Yang, JH ;
Chen, SU ;
Ho, HN ;
Yang, YS .
FERTILITY AND STERILITY, 2003, 80 (01) :86-90
[5]   Lysophosphatidic acid up-regulates expression of interleukin-8 and-6 in granulosa-lutein cells through its receptors and nuclear factor-κB dependent pathways:: Implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome [J].
Chen, Shee-Uan ;
Chou, Chia-Hung ;
Lee, Hsinyu ;
Ho, Chi-Hong ;
Lin, Chung-Wu ;
Yang, Yu-Shih .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03) :935-943
[6]  
Elchalal U, 1997, HUM REPROD, V12, P1129
[7]   The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study [J].
Engmann, Lawrence ;
DiLuigi, Andrea ;
Schmidt, David ;
Nulsen, John ;
Maier, Donald ;
Benadiva, Claudio .
FERTILITY AND STERILITY, 2008, 89 (01) :84-91
[8]  
Engrand P, 2001, J CLIN ENDOCR METAB, V86, P2607
[9]   Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model [J].
Gomez, Raul ;
Gonzalez-Izquierdo, Miguel ;
Zimmermann, Ralf C. ;
Novella-Maestre, Edurne ;
Alonso-Muriel, Isabel ;
Sanchez-Criado, Jose ;
Remohi, Jose ;
Simon, Carlos ;
Pellicer, Antonio .
ENDOCRINOLOGY, 2006, 147 (11) :5400-5411
[10]   Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles [J].
Nargund, Geeta ;
Hutchison, Lee ;
Scaramuzzi, Rex ;
Campbell, Stuart .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (06) :682-685
12